NCT04013360

Brief Summary

This study evaluates the efficacy and safety of a single session of positive expiratory pressure and of breath stacking technique in patients after cardiac surgery. The same patients will receive the two interventions, with an interval of 24 hours, and the acute effect of each will be verifed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 9, 2019

Completed
23 days until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2020

Completed
Last Updated

April 9, 2020

Status Verified

April 1, 2020

Enrollment Period

5 months

First QC Date

July 2, 2019

Last Update Submit

April 7, 2020

Conditions

Keywords

Cardiac SurgeryPositive End Expiratory PressurePhysical Therapy TechniquesPulmonary Funtcion

Outcome Measures

Primary Outcomes (2)

  • Tidal volume

    It will be evaluated preoperatively and also before and after 10 minutes of each intervention, in the postoperative period. This measurement will be obtained through the the division of the minute volume by the respiratory rate.

    12 to 24 hours after removal of drains and 24 hours after primary intervention

  • Forced vital capacity (FVC)

    It will be evaluated preoperatively and also before and after 10 minutes of each intervention, in the postoperative period, as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability \<5%) and considered the best curve for the study.

    12 to 24 hours after removal of drains and 24 hours after primary intervention

Secondary Outcomes (13)

  • Forced expiratory volume in the first second (FEV1)

    12 to 24 hours after removal of drains and 24 hours after primary intervention

  • Peak expiratory flow (PEF)

    12 to 24 hours after removal of drains and 24 hours after primary intervention

  • Forced expiratory flow between 25 and 75% of the curve of FVC (FEF25-75)

    12 to 24 hours after removal of drains and 24 hours after primary intervention

  • Minute volume

    12 to 24 hours after removal of drains and 24 hours after primary intervention

  • Respiratory rate

    12 to 24 hours after removal of drains and 24 hours after primary intervention

  • +8 more secondary outcomes

Study Arms (2)

Breath Stacking

ACTIVE COMPARATOR

Instrument composed of a one-way valve coupled to a face mask to promote the accumulation of successive inspiratory volumes.

Other: Breath StackingOther: Expiratory Positive Airway Pressure

Expiratory Positive Airway Pressure

ACTIVE COMPARATOR

Therapeutic technique consisting of a face mask, a one-way valve and an expiratory resistor, responsible for resistance to expiratory flow, which will determine the level of pressure in the airway.

Other: Breath StackingOther: Expiratory Positive Airway Pressure

Interventions

The patients will perform the maneuver through successive inspiratory efforts for 20 s. Subsequently, the expiratory branch will be unobstructed to allow expiration. This maneuver will be repeated 5 times in each series, with intervals of 30 seconds between them. The technique will be performed with the trunk inclined 30º in relation to the horizontal plane, in 3 series, with interval of 2 min completing 15 min of therapy.

Breath StackingExpiratory Positive Airway Pressure

Patients will perform exhalation of air through a facial mask containing an extrinsic positive expiratory pressure valve with a defined load of 10 cmH2O for 5 min. During the application of the technique the patients will have a trunk inclined 30º and will be stimulated to breathe normally, without effort or deep and fast breaths.

Breath StackingExpiratory Positive Airway Pressure

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with indication for coronary artery bypass grafting and valve replacement, with surgical procedure for median sternotomy.

You may not qualify if:

  • incapacity to understand the Informed Consent Form.
  • cognitive dysfunction that prevents the performance of evaluations or interventions,
  • intolerance to the use of EPAP or BS mask
  • with chronic obstructive pulmonary disease (COPD)
  • cerebrovascular disease
  • chronic-degenerative musculoskeletal disease
  • chronic infectious disease
  • in treatment with steroids, hormones or cancer chemotherapy
  • hemodynamic complications (arrhythmia, myocardial infarction during the operation, with blood loss ≥ 20% of the total blood volume, defined by Mannuci, et al., 2007)
  • mean arterial pressure \<70 mmHg and reduced cardiac output, requiring the use of intra aortic balloon or vasoactive drugs
  • tracheal intubation for more than 12 hours after admission to the ICU or reintubated
  • individuals unable to maintain airway permeability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal University of Santa Maria

Santa Maria, Rio Grande do Sul, 97105-900, Brazil

Location

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 2, 2019

First Posted

July 9, 2019

Study Start

August 1, 2019

Primary Completion

December 30, 2019

Study Completion

February 4, 2020

Last Updated

April 9, 2020

Record last verified: 2020-04

Locations